Sfoglia per Rivista CANCER RESEARCH
Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients
2013-01-01 Tel, J; Aarntzen, Ehjg; Baba, T; Schreibelt, G; Schulte, Bm; Benitez-Ribas, D; Boerman, Oc; Croockewit, S; Oyen, W; van Rossum, M; Winkels, G; Coulie, Pg; Punt, Cja; Figdor, Cg; de Vries, Ijm
Neonod Study: Conservation of axillary lymph nodes in the presence of micrometastases in the sentinel lymph node if cN- After neoadjuvant chemotherapy
2020-01-01 Tinterri, C; Marrazzo, E; Gatzemeier, W; Barbieri, E; Sagona, A; Bottini, A; Testori, A; Errico, V; Canavese, G
Nicotinamide Phosphoribosyltransferase (NAMPT) acts as a metabolic gate for mobilization of myeloid-derived suppressor cells
2019-01-01 Travelli, C; Consonni, Fm; Sangaletti, S; Storto, M; Morlacchi, S; Grolla, Aa; Galli, U; Tron, Gc; Portararo, P; Rimassa, L; Pressiani, T; Mazzone, M; Trovato, R; Ugel, S; Bronte, V; Tripodo, C; Colombo, Mp; Genazzani, Aa; Sica, A
Non-invasive estrogen receptor assessment by [F-18]-fluorestradiol(FES)-PET or circulating tumor cells predicts receptor status in patients with metastatic breast cancer
2019-01-01 Eisses, B; Angus, L; van der Vegt, B; Sieuwerts, Am; Kraan, J; Martens, Jw; Glaudemans, Aw; Brouwers, Ah; Hoekstra, Os; Oyen, W; Emmering, J; Gerritse, S; van Oordt, Cwm; Boon, E; van Herpen, Cm; Jager, A; Sleijfer, S; de Vries, Eg; Schroder, Cp
Noninvasive Imaging of Tumor PD-L1 Expression Using Radiolabeled Anti-PD-L1 Antibodies
2015-01-01 Heskamp, S; Hobo, W; Molkenboer-Kuenen, Jdm; Olive, D; Oyen, W; Dolstra, H; Boerman, Oc
Novel upfront sample enrichment nanotechnology identifies prostate, breast, colon, ovarian, lung, pancreatic, and melanoma cancer specific biomarker candidates
2012-01-01 Fredolini, C; Tamburro, D; Goud, S; King, C; Zhou, W; Russo, P; Espina, V; Novelli, F; Collura, D; D'Urso, L; Belluco, C; Muto, G; Garaci, E; Liotta, L; Petricoin, E; Luchini, A
OTX015 effects in triple-negative breast cancer (TNBC) models are independent of hypoxia conditions and synergistic with other anticancer agents
2015-01-01 Vazquez, R; Astorgues-Xerri, L; Riveiro, Me; Beltrame, L; Marchini, S; Bertoni, F; Kwee, I; Mohamed, M; Cvitkovic, E; Frapolli, R; D'Incalci, M
OTX015, a novel pan BET-BRD inhibitor is active in non-small-cell lung cancer (NSCLC) cell lines bearing the fusion protein EML4-ALK
2014-01-01 Vazquez, R; Astorgues-Xerri, L; Bekradda, M; Cvitkovic, E; Herait, P; Boi, M; Inghirami, G; D'Incalci, M; Riveiro, Me; Raymond, E
p130/pRb2 has a similar yet distinctive growth suppressive properties as retinoblastoma family members, pRb and p107
1994-01-01 Claudio, P. P.; Howard, C. M.; Baldi, A.; DE LUCA, A.; Fu, Y.; Condorelli, G; Sun, Y.; Colburn, N.; Calabretta, B.; Giordano, A.
p21(WAF1)-derived peptides linked to an internalization peptide inhibit human cancer cell growth
1997-01-01 Bonfanti, M; Taverna, S; Salmona, M; D'Incalci, M; Broggini, M
p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel
1997-01-01 Debernardis, D; Sire, Eg; Defeudis, P; Vikhanskaya, F; Valenti, M; Russo, P; Parodi, S; D'Incalci, M; Broggini, M
Pharmacological inactivation of DNA repair to improve response to immunotherapy: The Arethusa trial in metastatic colorectal cancer
2019-01-01 Marsoni, S; Germano, G; Bianchi, As; Pietrantonio, F; Personeni, N; Amatu, A; Bonoldi, E; Valtorta, E; Barault, L; Di Nicolantonio, F; de Braud, F; Rimassa, L; Santoro, A; Ghezzi, S; Cassingena, A; Marrapese, G; Lupica, L; Siravegna, G; Rospo, G; Martino, C; Lazzari, L; Luraghi, P; Amirouchene-Angelozzi, N; Bardelli, A; Siena, S
Plasma antibodies to oral pathogen and commensals and risk of pancreatic cancer in a large European prospective cohort study
2012-01-01 Michaud, Ds; Izard, J; Wilhelm-Benartzi, C; Riboli, E; Bueno-de-Mesquita, B
PM01183 shows an improved therapeutic index relative to trabectedin and suppresses EWS/FLI1 activity at clinically achievable concentrations
2014-01-01 Harlow, M; Maloney, N; Navarro, Mjg; D'Incalci, M; Galmarini, C; Marin, Pma; Grohar, P
Polymorphisms in the alcohol dehydrogenase (ADH1) gene cluster, alcohol consumption, and interactions in relation to gastric cancer risk in the EPIC cohort
2011-01-01 Duell, Ej; Sala, N; Munoz, X; Travier, N; Lujan-Barroso, L; Riboli, E; Gonzalez, Ca
Preservation of axillary lymph nodes compared to complete dissection in T1-T2 breast cancer patients presenting 1-2 metastatic sentinel lymph nodes: A multicenter randomized clinical trial. Sinodar One Stud
2020-01-01 Tinterri, C
Preservation of axillary lymph nodes compared to complete dissection in T1-T2 breast cancer patients presenting 1-2 metastatic sentinel lymph nodes: A multicenter randomized clinical trial. Sinodar One Study
2020-01-01 Tinterri, C; Marrazzo, E; Frusone, F; Gatzemeier, W; Barbieri, E; Sagona, A; Bottini, A; Errico, V; Testori, A; Canavese, G
Pretargeted Dual-Modality Immuno-SPECT and Near-Infrared Fluorescence Imaging for Image-Guided Surgery of Prostate Cancer
2014-01-01 Lutje, S; Rijpkema, M; Goldenberg, Dm; van Rij, Cm; Sharkey, Rm; Mcbride, Wj; Franssen, Gm; Frielink, C; Helfrich, W; Oyen, W; Boerman, Oc
Pretargeted immunoPET for imaging human colonic cancer in a mouse model
2011-01-01 Schoffelen, R; Franssen, Gm; Mcbride, Wj; Disselhorst, Ja; Sharkey, Rm; Laverman, P; van der Graaf, Wta; Oyen, W; Goldenberg, Dm; Boerman, Oc
Pretargeted radioimmunotherapy of an anti-CEA bispecific antibody and Lu-177-labeled peptide: a phase I study in patients with advanced colorectal cancer
2012-01-01 Schoffelen, R; Boerman, Oc; Goldenberg, Dm; Sharkey, Rm; Herpen, Cml; Chang, Ch; Franssen, Gm; Mcbride, Wj; Rossi, Ea; van der Graaf, Wta; Oyen, W
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients | 1-gen-2013 | Tel, J; Aarntzen, Ehjg; Baba, T; Schreibelt, G; Schulte, Bm; Benitez-Ribas, D; Boerman, Oc; Croockewit, S; Oyen, W; van Rossum, M; Winkels, G; Coulie, Pg; Punt, Cja; Figdor, Cg; de Vries, Ijm | |
| Neonod Study: Conservation of axillary lymph nodes in the presence of micrometastases in the sentinel lymph node if cN- After neoadjuvant chemotherapy | 1-gen-2020 | Tinterri, C; Marrazzo, E; Gatzemeier, W; Barbieri, E; Sagona, A; Bottini, A; Testori, A; Errico, V; Canavese, G | |
| Nicotinamide Phosphoribosyltransferase (NAMPT) acts as a metabolic gate for mobilization of myeloid-derived suppressor cells | 1-gen-2019 | Travelli, C; Consonni, Fm; Sangaletti, S; Storto, M; Morlacchi, S; Grolla, Aa; Galli, U; Tron, Gc; Portararo, P; Rimassa, L; Pressiani, T; Mazzone, M; Trovato, R; Ugel, S; Bronte, V; Tripodo, C; Colombo, Mp; Genazzani, Aa; Sica, A | |
| Non-invasive estrogen receptor assessment by [F-18]-fluorestradiol(FES)-PET or circulating tumor cells predicts receptor status in patients with metastatic breast cancer | 1-gen-2019 | Eisses, B; Angus, L; van der Vegt, B; Sieuwerts, Am; Kraan, J; Martens, Jw; Glaudemans, Aw; Brouwers, Ah; Hoekstra, Os; Oyen, W; Emmering, J; Gerritse, S; van Oordt, Cwm; Boon, E; van Herpen, Cm; Jager, A; Sleijfer, S; de Vries, Eg; Schroder, Cp | |
| Noninvasive Imaging of Tumor PD-L1 Expression Using Radiolabeled Anti-PD-L1 Antibodies | 1-gen-2015 | Heskamp, S; Hobo, W; Molkenboer-Kuenen, Jdm; Olive, D; Oyen, W; Dolstra, H; Boerman, Oc | |
| Novel upfront sample enrichment nanotechnology identifies prostate, breast, colon, ovarian, lung, pancreatic, and melanoma cancer specific biomarker candidates | 1-gen-2012 | Fredolini, C; Tamburro, D; Goud, S; King, C; Zhou, W; Russo, P; Espina, V; Novelli, F; Collura, D; D'Urso, L; Belluco, C; Muto, G; Garaci, E; Liotta, L; Petricoin, E; Luchini, A | |
| OTX015 effects in triple-negative breast cancer (TNBC) models are independent of hypoxia conditions and synergistic with other anticancer agents | 1-gen-2015 | Vazquez, R; Astorgues-Xerri, L; Riveiro, Me; Beltrame, L; Marchini, S; Bertoni, F; Kwee, I; Mohamed, M; Cvitkovic, E; Frapolli, R; D'Incalci, M | |
| OTX015, a novel pan BET-BRD inhibitor is active in non-small-cell lung cancer (NSCLC) cell lines bearing the fusion protein EML4-ALK | 1-gen-2014 | Vazquez, R; Astorgues-Xerri, L; Bekradda, M; Cvitkovic, E; Herait, P; Boi, M; Inghirami, G; D'Incalci, M; Riveiro, Me; Raymond, E | |
| p130/pRb2 has a similar yet distinctive growth suppressive properties as retinoblastoma family members, pRb and p107 | 1-gen-1994 | Claudio, P. P.; Howard, C. M.; Baldi, A.; DE LUCA, A.; Fu, Y.; Condorelli, G; Sun, Y.; Colburn, N.; Calabretta, B.; Giordano, A. | |
| p21(WAF1)-derived peptides linked to an internalization peptide inhibit human cancer cell growth | 1-gen-1997 | Bonfanti, M; Taverna, S; Salmona, M; D'Incalci, M; Broggini, M | |
| p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel | 1-gen-1997 | Debernardis, D; Sire, Eg; Defeudis, P; Vikhanskaya, F; Valenti, M; Russo, P; Parodi, S; D'Incalci, M; Broggini, M | |
| Pharmacological inactivation of DNA repair to improve response to immunotherapy: The Arethusa trial in metastatic colorectal cancer | 1-gen-2019 | Marsoni, S; Germano, G; Bianchi, As; Pietrantonio, F; Personeni, N; Amatu, A; Bonoldi, E; Valtorta, E; Barault, L; Di Nicolantonio, F; de Braud, F; Rimassa, L; Santoro, A; Ghezzi, S; Cassingena, A; Marrapese, G; Lupica, L; Siravegna, G; Rospo, G; Martino, C; Lazzari, L; Luraghi, P; Amirouchene-Angelozzi, N; Bardelli, A; Siena, S | |
| Plasma antibodies to oral pathogen and commensals and risk of pancreatic cancer in a large European prospective cohort study | 1-gen-2012 | Michaud, Ds; Izard, J; Wilhelm-Benartzi, C; Riboli, E; Bueno-de-Mesquita, B | |
| PM01183 shows an improved therapeutic index relative to trabectedin and suppresses EWS/FLI1 activity at clinically achievable concentrations | 1-gen-2014 | Harlow, M; Maloney, N; Navarro, Mjg; D'Incalci, M; Galmarini, C; Marin, Pma; Grohar, P | |
| Polymorphisms in the alcohol dehydrogenase (ADH1) gene cluster, alcohol consumption, and interactions in relation to gastric cancer risk in the EPIC cohort | 1-gen-2011 | Duell, Ej; Sala, N; Munoz, X; Travier, N; Lujan-Barroso, L; Riboli, E; Gonzalez, Ca | |
| Preservation of axillary lymph nodes compared to complete dissection in T1-T2 breast cancer patients presenting 1-2 metastatic sentinel lymph nodes: A multicenter randomized clinical trial. Sinodar One Stud | 1-gen-2020 | Tinterri, C | |
| Preservation of axillary lymph nodes compared to complete dissection in T1-T2 breast cancer patients presenting 1-2 metastatic sentinel lymph nodes: A multicenter randomized clinical trial. Sinodar One Study | 1-gen-2020 | Tinterri, C; Marrazzo, E; Frusone, F; Gatzemeier, W; Barbieri, E; Sagona, A; Bottini, A; Errico, V; Testori, A; Canavese, G | |
| Pretargeted Dual-Modality Immuno-SPECT and Near-Infrared Fluorescence Imaging for Image-Guided Surgery of Prostate Cancer | 1-gen-2014 | Lutje, S; Rijpkema, M; Goldenberg, Dm; van Rij, Cm; Sharkey, Rm; Mcbride, Wj; Franssen, Gm; Frielink, C; Helfrich, W; Oyen, W; Boerman, Oc | |
| Pretargeted immunoPET for imaging human colonic cancer in a mouse model | 1-gen-2011 | Schoffelen, R; Franssen, Gm; Mcbride, Wj; Disselhorst, Ja; Sharkey, Rm; Laverman, P; van der Graaf, Wta; Oyen, W; Goldenberg, Dm; Boerman, Oc | |
| Pretargeted radioimmunotherapy of an anti-CEA bispecific antibody and Lu-177-labeled peptide: a phase I study in patients with advanced colorectal cancer | 1-gen-2012 | Schoffelen, R; Boerman, Oc; Goldenberg, Dm; Sharkey, Rm; Herpen, Cml; Chang, Ch; Franssen, Gm; Mcbride, Wj; Rossi, Ea; van der Graaf, Wta; Oyen, W |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile